InsidersTradesSigma
Track the VERACYTE INC share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.6bn. The latest transaction was reported on 4 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MARC STAPLEY. The full history is free.
Analysts rate VERACYTE INC Buy (bullish), based on 11 analysts. Average price target: US$57.82.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Veracyte Inc es una empresa de diagnóstico molecular que ofrece pruebas para ayudar en la toma de decisiones clínicas en el sector de la salud. Cotiza en el NASDAQ bajo el símbolo VCYT.